Biguanide metformin (MF), a first-line drug for the treatment of type 2 diabetes mellitus (T2DM), is widely used to normalize insulin sensitivity and improve glucose and lipid metabolism in patients with T2DM and metabolic syndrome [1,2,3,4]. The gene discussed is INS; the disease is diabetes mellitus.